-
The lancet oncology · Feb 2018
Comment LetterNegative phase 3 study of 90Y microspheres versus sorafenib in HCC.
- Etienne Garin, Yan Rolland, Boris Campillo-Gimenez, and Julien Edeline.
- Department of Nuclear Medicine, Cancer Institute Eugène Marquis, Avenue de la Bataille Flandres-Dunkerque, CS 44229, 35042 Rennes cedex, France; University of Rennes 1, 35033 Rennes, France; INSERM, INRA, Univ Rennes 1, Univ Bretagne Loire, Nutrition Metabolism and Cancer (NuMeCan), Rennes, France. Electronic address: e.garin@rennes.unicancer.fr.
- Lancet Oncol. 2018 Feb 1; 19 (2): e70.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.